While REG3α concentrations did not differ significantly between normal-weight, overweight, and obesity groups, the peptide showed significant associations with vitamin D supplementation and with inflammatory biomarkers such as β-defensin-2 and IL-6, supporting a potential link between mucosal immune activity and metabolic inflammation. Here, REG3A is linked to obesity due to melanocortin 4 receptor deficiency.